Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial

Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian

Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)

Guardian Pharmacy Services to report quarterly results, host conference call

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

Global Sales Surge: Is This Billion-Dollar Industry Being Elevated by Relaxation-Seeking Middle Class?

Guardian Pharmacy Services’ SVP, general counsel Douglas Towns files Form 3 ownership statement

Guardian Pharmacy Services SVP Jeffrey Tuch files initial beneficial ownership statement

Guardian Pharmacy Svcs Is Maintained at Buy by Truist Securities

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sundrug Co (OtherSDGCF) and Verastem (VSTM)

C-RAD Targets Profitable Growth as Demand for Advanced Radiotherapy Solutions Rises

111, Inc. Posts 2025 Profitability Milestone as Asset-Light Pivot Lifts Margins

111 Inc. Achieves Full-Year Revenue of RMB 12.6 Billion in 2025, Reaches Operating Profitability in Q4 and Full Year

111 Q4 Adj. EPS $(0.20) Down From $(0.04) YoY, Sales $403.278M Down From $527.143M YoY

111 Inc FY25 net loss widens to RMB 22.5 million; net revenues fall 12.8% to RMB 12.6 billion

111 Inc - Q4 2025 Net Revenues RMB2.8 Bln; Gross Segment Profit RMB164.9 Mln

111 Inc - FY2025 Net Revenues RMB12.6 Bln; Gross Segment Profit RMB723.4 Mln

Press Release: 111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:46 AM